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ABSTRACT
Bone mineral density (BMD) and fracture risk are elevated in adults with impaired fasting glucose
(IFG) or type 2 diabetes mellitus (T2D). This study aimed to compare bone health among Inuit
women with IFG, T2D and normoglycemia. The study included Inuit women (≥40 y) with IFG
(n = 57), T2D (n = 72) or normoglycemia (n = 340) from the International Polar Year Inuit Health
Survey 2007–2008 in Canada. Distal one-third forearm BMD (FaBMD) was measured using a
peripheral instantaneous x-ray imager. Anthropometry, fasting plasma glucose (FPG), serum
adiponectin, leptin and 25-hydroxyvitamin D (25(OH)D) were measured. Traditional food intakes
were surveyed. Data were analysed using mixed model ANOVA and regression models. The
median age was 53 (IFG: IQR 48, 67) y and 56 (T2D: IQR 49, 63) y. Compared to normoglycemic
women, FaBMD and T-scores were significantly lower in women with T2D, but not with IFG.
Frequency of marine mammal intakes (ß = 0.145; 95%CI: 0.018, 0.053, p = 0.0001) positively
related to FaBMD. The odds ratio of having a T-score consistent with osteoporosis was lower
among women with T2D and higher BMI, while aging increased the risk. Although T2D associates
with lower BMD among Inuit women, risk of osteoporosis is tempered, possibly by maintenance
of a traditional lifestyle.
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Type 2 diabetes mellitus (T2D) is paradoxically related to
increased risk of fractures despite normal to elevated areal
bone mineral density (BMD) relative to normoglycemic
controls [1]. In a meta-analysis, T2D was associated with
positive Z-scores for BMD of the lumbar spine (0.41 ± 0.01)
and hip (0.27 ± 0.01) [2], which could be primarily ascribed
to elevated body mass index (BMI). This is an important
consideration since in a study of postmenopausal women,
those with T2D and an overweight BMI had greater BMD
of the spine and hip compared to controls, whereas those
with T2D and a healthy BMI had lower BMD [3].
Furthermore, poorly controlled T2D on the basis of a
haemoglobin A1c (HbA1c) ≥ 7.5% associates with greater
BMD of lumbar spine and hip and greater fracture risk
relative to controls, but this is not observed when T2D is
adequately controlled [4]. Similarly, lumbar spine BMD of
postmenopausal women with T2D on average in poor
control (fasting plasma glucose (FPG) of 9.1 mmol/L), is
higher than controls, but still in the osteoporotic range (T-
score −2.84 ± 0.42) [5]. There is also evidence that T2D
associates with greater loss of BMD at the femoral neck,
which may predispose to fracture [6].
In addition to T2D, ethnic variation in BMD and
fracture risk may relate to genetic, anthropometric,
and lifestyle factors [7]. Being of First Nations
(Aboriginal Canadian) ethnicity was among the predic-
tors of fracture in an age, sex and region matched case
control study in Canada [8]. In that study, having T2D
increased the risk of any fracture (rate ratio: 1.26; 95%
CI: 1.19, 1.34). Similarly, the incidence of fracture was
higher for Inuit women over 64 y in Alaska relative to
white US women [9]. Neither of these studies was able
to report upon BMD and its association with BMI and
T2D. In the International Polar Year Inuit Health Survey
(IPY-IHS), BMI and age were the most important corre-
lates of BMD among Inuit women [10]. In Greenland,
age was the most important predictor of fragility frac-
ture independent of family history, lifestyle and medi-
cation use [11]. The prevalence of T2D, once considered
rare among Inuit, is 12.2% (95% CI: 8.7%, 15.7%) among
adults ≥ 50 y [12]. To our knowledge, no studies have
examined the association between BMD and impaired
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fasting glucose (IFG) or T2D among Inuit, both of which
increase with adiposity and age.
Other factors that accompany the rise in IFG and T2D
among Inuit include the nutrition transition, charac-
terised by reduced traditional food consumption, n-3
fatty acid intakes [13] and vitamin D status [10].
Traditional food patterns including an abundance of
fish and seafood associate with lower HbA1c [14] and
both vitamin D and n-3 fatty acids are, in part, consid-
ered protective against fracture risk [15,16]. In addition,
elevated leptin and reduced adiponectin are observed
in First Nations adults with T2D relative to normogly-
cemic adults [17]. Higher circulating leptin associates
with increased BMD and lower fracture risk, whereas
adiponectin inversely associates with BMD [18]. Data on
BMD and its association with IFG or T2D in Inuit women
are scarce. Hence, the goals of this study were to (1)
compare forearm BMD (FaBMD), and FaBMD T-scores
between Inuit women with IFG or T2D to normoglyce-
mic women; (2) assess whether biomarkers and dietary
factors that accompany IFG and T2D associate with
FaBMD; and (3) explore whether the risk of osteoporosis
is elevated by IFG and T2D. We hypothesised that
FaBMD would not be significantly higher in T2D and
IFG cases compared to normoglycemic women, and
that IFG and T2D risk factors including low traditional
food intakes would associate with BMD.
Methods
Study population and ethical approval
Data were obtained from the cross-sectional IPY-IHS of
adults residing in 36 Arctic communities in the late
summer and early fall of 2007 (August–September)
and 2008 (August-–October). Details of the IPY-IHS sur-
vey are published in full elsewhere [19]. The survey
included all communities in three jurisdictions:
Inuvialuit Settlement Region (ISR), Nunavut and
Nunatsiavut. The communities are located between
54°10ʹ and 74°43ʹ north. Stratified random sampling
was used to select households where communities
were strata and where homes were randomly selected
using either a computer random generation of numbers
or a random digit table. The household participation
rate was 68% and 2595 male and non-pregnant female
adults were included in the main survey.
Assessment of FaBMD was performed only in women
≥40 y of age (n = 570, 22.0% of the survey participants).
From the total sample, women with IFG or T2D with
data available for FaBMD were compared to normogly-
cemic women (n = 340; FPG values < 5.6). IFG (n = 57)
was defined by FPG values ≥ 5.6 to 6.9 mmol/L [20],
whereas T2D (n = 72) was ascertained if a participant
had a prior diagnosis of T2D (n = 53); or if the survey
results for FPG exceeded 7 mmol/L (n = 15) or if 2-h
plasma glucose exceeded 11.1 mmol/L (n = 4) following
an oral glucose tolerance test [21]. Among those with a
prior diagnosis of T2D, n = 21 of 53 reported details of
medical therapy for T2D (n = 12 were using metformin,
n = 3 were using glyburide and n = 1 was using insulin
and metformin, in addition to 5 with non-specified type
of medications).
The study was reviewed and approved by the McGill
University, Faculty of Medicine Research Ethics Board,
the Nunavut Research Institute and the Aurora Research
Institute. Signed informed consent was obtained from
each participant.
Dietary assessment
Data on dietary habits were collected using a food
frequency questionnaire (FFQ) administered by trained
bilingual (English and Inuit dialects) interviewers [19].
The FFQ was customised to capture information within
the past year about Inuit traditional food items that are
abundant in the regions of the study. Inuit adults were
asked about how often in the last year they consumed
(in season or off season) traditional food items from a
list of 47 items. Data were combined into total tradi-
tional foods, total marine mammals and total fish and
expressed as a frequency of intake per day.
Clinical assessment
A portable stadiometer (Road Rod 214 Portable stadi-
ometer, Seca, Maryland, USA) was used to measure
height to the nearest 0.1 cm. Body weight was recorded
to the nearest 0.1 kg and 0.4 kg was subtracted to
account for clothes; body fat % was measured using
the same scale (Tanita TBF-300GS, Tanita Corporation of
America Inc. Arlington Height, Illinois). Participants who
had pacemakers had their weight measured by a Seca
Scale (Medical Scale Model 214, Seca Corp., Toronto,
Ontario), BMI was then calculated.
Areal BMD of the distal one-third forearm (FaBMD)
was evaluated by a registered x-ray technologist using a
peripheral instantaneous x-ray imager (PIXI; GE/Lunar,
Fort Myers, FL). Before performance of any assessment,
the equipment underwent quality control using the
forearm phantom every day; long-term precision error
was 0.5%. In vivo variability was calculated as percent
coefficient of variation (CV) by doing three repeated
measures on randomly selected participants per day;
one was measured in the beginning of the day and
the other at the end of the day yielding an average
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CV of 1.7%. The proprietary reference data were col-
lected in the United States using the same PIXI model.
T-scores were calculated using manufacturer’s reference
data of ambulatory white premenopausal women who
were 20–45 years of age with no history of chronic
disease or medications affecting bone and no history
of symptomatic, atraumatic fractures. The World Health
Organization definition for osteoporosis and osteopenia
was used [22]: a FaBMD T-score of ≤−2.5 was consid-
ered as osteoporosis, whereas a FaBMD T-score of −1 to
−2.4 was considered to be osteopenia (low bone mass)
and values >−1 considered normal.
Smoking habits were surveyed. Medication use in
the previous year (2006 or 2007) was ascertained from
answers to standardised questionnaires. Participants
were instructed to bring their medications and supple-
ments to their survey appointment for accurate docu-
mentation by nurses. For the purposes of this analysis,
antihypertensive/cardiac, lipid lowering and proton
pump inhibitor medications were explored due to the
possible relationship to BMD and fracture risk [23,24].
Laboratory analyses
Serum 25-hydroxyvitamin D (25(OH)D) reflects both
endogenous and exogenous vitamin D sources. Serum
total 25(OH)D and intact parathyroid hormone (PTH) 1–
84 were measured using chemiluminescent assays
(Liaison, Diasorin Inc, Stillwater, MN, USA) [10]. The
inter- and intra-assay CV% were 4.5% and 11.1% for
the low 25(OH)D control (38.2 nmol/L) and 6.2% and
5.3% for high control (127.2 nmol/L), respectively. The
inter-assay CV% for PTH was 19.1 (5.2 pmol/L) for the
low control and 8.7 (52.1 pmol/L) for the high PTH
control. The accuracy using the mid-range of the man-
ufacturer specifications was 95% for 25(OH)D and 86.7%
for PTH. The laboratory that performed the measure-
ment for 25(OH)D was certified by the Vitamin D
External Quality Assessment Scheme for the year
2009–2010 when the IPY-IHS samples were measured,
which reflects that at least 80% of the results in this
report are within 30% of all laboratory trimmed mean.
Serum adiponectin was measured using an Ultra-
Sensitive Human Cytokine Assay kit using a Meso Scale
Discovery Multi-Array Assay (MSD cat#K151BXC) System
and a detection limit of 0.005 µg/mL. Serum leptin was
measured using amanual sandwich ELISA assay (Linco cat#
EZHL-80SJK, Linco Research, St Charles, Missouri) with a
detection limit of 0.5 µg/L. For adiponectin, the intra-
assay and inter-assay CV were 5% and 15%, respectively,
whereas for leptin, the intra-assay and inter-assay CV were
10%. Samples for FPG and serum insulin were kept at 4°C,
until plasma was separated and frozen at −80°C, and then
assayed for glucose by Glucose Hexokinase IImethod. All of
these analyses were conducted by Nutrasource
Diagnostics, Guelph, ON.
Red blood cell (RBC) membrane fatty acid (FA) pro-
files, expressed as percent of total FA, were determined
using the methodology of Folch et al. [25]. Fatty acid
methyl esters were prepared with boron trichloride-
methanol to reduce artifact formation and separated
on a Varian 3400 gas–liquid chromatograph with a 60-
m DB-23 capillary column (0.32 mm diameter). Methods
are described in detail elsewhere [26]. The RBC propor-
tion of omega-3 fatty acid (RBC-Omega-3) included all
of the n-3 FA from 18:3 n-3 to 22:6 n-3.
Statistical analyses
Differences between IFG and T2D groups and normo-
glycemic women were evaluated using mixed model
ANOVAs; group, region and medication use were tested
as fixed effects. Proportions were compared using Chi-
square or Fisher’s exact tests.
The association between biomarkers and FFQ vari-
ables and FaBMD, and T-scores were tested using multi-
ple linear regression models adjusting for group, age,
height, BMI, smoking and region; and medication use
which is often different for IFG and T2D. Frequency of
alcohol consumption and exercise were not included
due to the high frequency of unanswered survey ques-
tions. Final regression models were checked for residual
distribution and normality, influential points, and colli-
nearity using the variance inflation factor. Risk of having
a T-score consistent with osteoporosis was explored
using logistic regression. Statistical significance was
evaluated using a p-value < 0.05 (2-tailed).
Results
Age, adiposity, and anthropometric measurements
were the lower in normoglycemic women compared
to IFG and T2D cases (Table 1). Serum 25(OH)D and
leptin concentrations and prevalence of smoking, anti-
hypertensive and lipid lowering medications, and vita-
min and mineral supplement use were higher in T2D
cases than normoglycemic women. Arctic region of
residence did not vary by glycemic status.
No differences were observed in FaBMD, T-scores or
proportions with osteopenia and osteoporosis among IFG
cases and normoglycemic women (Table 2). However,
FaBMD and T-scores were lower in T2D cases compared
to normoglycemic women in models adjusting for age and
region. The parameters in the regression models that
explained FaBMD included age, height, BMI, intake of mar-
ine mammals, smoking and region of residence (Table 3);
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T2Dwas not significantly associatedwith FaBMDwhen BMI
was included in themodel. Biomarkers (adiponectin, leptin,
25(OH)D),medicationor supplementusedidnot contribute
to the regression model for FaBMD. The above-mentioned
resultswere similar to the results obtainedwhen evaluating
FaBMD T-scores (data not shown). The odds ratio of having
a T-score consistent with osteoporosis (Figure 1) was
reduced by having T2D (OR 0.228; 95%CI 0.062, 0.833)
and a greater BMI (OR 0.863; 95%CI 0.794, 0.937) and
elevated with advancing age (OR 1.209; 95% CI 1.152,
1.270), but not by having IFG (OR 0.467; 95%CI 0.135, 1.605).
Discussion
This study addressed the relationship between IFG, T2D
and their risk factors with bone health measures among
Inuit women ≥40 y in the Canadian Arctic. Overall,
FaBMD was not in the osteoporotic range and no
Table 1. Health and lifestyle characteristics of Inuit women with impaired fasting glucose (IFG) or diabetes mellitus type 2 (T2D) and
a normoglycemic group.
Variable IFGa (n = 57) T2Db (n = 72) Normoglycemic (n = 340)
Age (y) 53 (48, 63)*** 56 (49.0, 63.0)*** 48 (43.0, 55.0)
Height (m) 1.52 (1.49, 1.55) 1.53 (1.50, 1.56) 1.53 (1.50, 1.57)
Adiposity indicators
BMI (kg/m2) 31.7 (25.5, 35.1)** 32.5 (27.0, 37.7)*** 28.1 (23.6, 32.8)
Waist circumference (cm) 97.4 (85.0, 108.1)** 102.9 (93.4, 116.3)*** 92.0 (80.0, 103.0)
Fat mass (%) 41.2 (34.3, 44.7)** 42.5 (36.7, 46.6)*** 36.7 (28.2, 42.1)
Biochemistry
Fasting pl. glucose (mmol/L) 5.9 (5.7, 6.0)*** 6.1 (5.5, 6.8) c*** 4.9 (4.6, 5.1)
Fasting s. insulin (µIU/mL) 12.4 (7.1, 17.7)*** 11.1 (7.8, 17.0)*** 6.9 (4.3, 10.6)
RBC-Omega-3 (%) 8.1 (6.2, 10.3) 7.9 (5.8, 10.5) 7.3 (5.2, 9.2)
Serum 25(OH)D (nmol/L) 78.6 (59.2, 99.1) 82.4 (61.8, 115.7)*** 67.9 (51.2, 88.4)
Serum PTH (pmol/L) 4.6 (3.4, 5.6) 4.4 (3.6, 5.4) 4.2 (3.3, 5.5)
Serum adiponectin (µg/mL) 11.8 (6.9, 16.0) 10.3 (6.7, 14.3) 11.2 (7.4, 17.3)
Serum leptin (µg/L) 24.8 (12.2, 42.1) 27.4 (15.4, 43.8)** 17.7 (8.6, 31.6)
FFQ (frequency of intake/d)
Total traditional food 0.77 (0.50, 1.33) 2.00 (0.61, 2.12) 1.01 (0.44, 1.87)
Marine mammals 0.08 (0.04, 0.29) 0.15 (0.03, 0.63) 0.09 (0.02, 0.35)
Fish 0.14 (0.04, 0.29) 0.29 (0.08, 0.48) 0.17 (0.07, 0.44)
Smoker (n (%)) 25 (43.9%) 39 (54.2%)* 110 (32.4%)
Medications (n (%))
Anithypertensive/cardiac 12 (21.1%) 35 (48.6%)*** 57 (16.8%)
Lipid lowering 8 (14.0%) 21 (29.2%)*** 20 (5.9%)
Proton pump inhibitors 8 (14.0%) 14 (19.4%) 27 (7.9%)
Vitamin/mineral supplements 3 (5.3%) 13 (18.1%)* 42 (12.4%)
Region (n (%))d
Nunavut 46 (80.7%) 49 (68.1%) 242 (71.2%)
Inuvialuit settlement Region 1 (1.8%) 4 (55.6%) 29 (8.5%)
Nunatsiavut 10 (17.5%) 19 (26.4%) 69 (20.3%)
Data are median (IQR) for continuous variables and as n (%) proportions for categorical variables within columns.
Comparisons were made using mixed model ANOVA for paired data and by Chi-square or Fisher’s exact test for proportions.
*p < 0.05, **p < 0.01, ***p < 0.0001 vs control.
aIFG defined by FPG values ≥ 5.6 to 6.9 mmol/L.
bT2D defined by either a prior diagnosis, a FPG > 7 mmol/L, or a 2-h OGTT glucose value > 11.1 mmol/L.
c Includes women with T2D controlled by medication.
d Data are proportions within group.
Medications and supplements: antihypertensive/cardiac medications included diuretics, calcium channel blockers, beta blockers, angiotensin converting
enzymes, digoxin, nitroglycerine, ASA and antiarrhythmic medications; lipid lowering medications included statins (3-hydroxy-3-methylglutaryl coenzyme
A reductase inhibitors); proton pump inhibitors (Omeprazole, Pantoprazole, Rabeprazole); vitamin/mineral supplements (type not specified).
Abbreviations: BMI, body mass index; FFQ, food frequency questionnaire reflecting 1 year; FPG: fasting plasma glucose; 25(OH)D, 25-hydroxyvitamin D; IFG,
impaired fasting glucose; PTH, parathyroid hormone; RBC-Omega-3,Omega-3 fatty acid content of red blood cells; T2D, type 2 diabetes mellitus.
Table 2. Bone health variables among Inuit women with
impaired fasting glucose (IFG) or diabetes mellitus type 2









FaBMD (g/cm2) 0.455 ± 0.012 0.459 ± 0.009* 0.470 ± 0.004
FaBMD T-score −0.57 ± 0.19 −0.51 ± 0.15* −0.32 ± 0.07
WHO Classification of
T-Scored (n (%))
Normal 36 (63.2%) 45 (62.5%) 249 (73.2%)
Osteopenia 15 (26.3%) 22 (30.6%) 62 (18.2%)
Osteoporosis 6 (10.5%) 5 (6.9%) 29 (8.5%)
aIFG defined by FPG values ≥ 5.6 to 6.9 mmol/L.
bT2D defined by either a prior diagnosis, a FPG > 7 mmol/L, or a 2-h OGTT
glucose value > 11.1 mmol/L.
c Data are unadjusted mean ± SE. Groups were compared after adjusting
for age and region (Nunavut, Inuvialuit Settlement Region, Nunatsiavut)
using mixed model ANOVA for paired data and by Chi-square or Fisher’s
exact test for proportions. * p < 0.05 vs controls.
d Data are proportions within group.
Abbreviations: FaBMD, distal one-third forearm bone mineral density; FPG:
fasting plasma glucose; IFG, impaired fasting glucose; T2D, type 2 dia-
betes mellitus; WHO, World Health Organization.
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adverse associations with either IFG or T2D were
observed after accounting for age and BMI.
Remarkably, the women with a diagnosis of T2D were
in very good glucose control with the median FPG
below 7 mmol/L (6.1, IQR 5.5, 6.8), and a lower odds
ratio of having osteoporosis in the distal forearm. In
contrast, other studies found that T2D associates with
higher BMD and T-scores [4,5] and that bone material
strength is paradoxically reduced in women with DM2
in association with inadequate long-term glucose con-
trol (average HbA1c over 10 years) [27]. Our study adds
to the growing body of evidence that reinforces the
importance of considering glycemic control in examin-
ing the relationships between T2D and bone health and
offers new perspectives on the beneficial role of tradi-
tional food for Inuit.
Among the traditional food variables, only frequency
of intake of marine mammals positively related to
FaBMD. The frequency of consuming fish was not dif-
ferent among the IFG, T2D cases and normoglycemic
women, the homogeneous sample likely explains the
lack of significance of fish in the regression model. Fish
was a commonly consumed traditional food in the
overall survey (median (IQR) of 0.11 (0.02, 0.30)), with
a younger mean age of 42 ± 15 y [28]. Similar to fish,
marine mammals are rich in omega-3 polyunsaturated
FA [26] and vitamin D [10] that are beneficial to bone
health [15,16]. Interestingly, neither serum 25(OH)D or
RBC-Omega-3 were related to FaBMD in the current
study population, although RBC-Omega-3 approached
significance (p = 0.086) in the regression model (data
not shown). These biological markers, however, reflect a
shorter exposure duration relative to the one year
assessment of traditional food intakes. Similar to our
findings, in postmenopausal Chinese women BMD was
3.2–6.8% higher in the top quintile compared to lowest
quintile of traditional sea fish intake [29] and higher
frequency of intakes of fish in a meta-analysis asso-
ciated with reduced risk of T2D [30]. Traditional food
patterns including fish and seafood also associate with
lower HbA1c [14]. Our observation that marine mammal
intakes were associated with greater FaBMD could be
ascribed to the benefits of traditional food intakes on
glucose control [30]. Collectively, these studies under-
score the benefits of traditional foods, which should be
highlighted as a source of omega-3 and vitamin D, and
beneficial to bone health.
Insulin is known to promote an increase in BMD [31],
likely through suppression of bone turnover, and fast-
ing insulin, as expected [31], was higher among IFG and
T2D cases than normoglycemic women in this study. In
contrast to previous research where adiponectin inver-
sely relates to BMD [18], adiponectin did not help to
explain the variability in BMD in our regression ana-
lyses. It is important to mention that BMD, including
that of the forearm, is not an indicator of bone quality,
as T2D is associated with increased porosity in bone
and accumulation of collagen advanced glycation end-
products, which may increase the risk of fracture
[32,33]. The association between T2D and increased
fracture risk is more commonly observed at the hip
and spine, compared to the wrist or forearm [8]. Thus,
future studies should incorporate assessments of the
axial skeleton and femoral neck regions. Further studies
are also needed to assess the longitudinal impact of IFG
Table 3. Beta coefficients and 95% confidence intervals (CI) for distal one-third forearm bone mineral density in Inuit women 40 y of
age and over.
Variable β-coefficient 95%CI p-value
Age (y) −0.586 −0.006, −0.004 <0.0001
Height (m) 0.134 0.088, 0.298 0.003
BMI (kg/m2) 0.283 0.003, 0.004 <0.0001
Marine mammals (frequency of intake/d) 0.145 0.018, 0.053 0.0001
Smoking (reference = no) −0.085 −0.001, −0.027 0.035
Region (reference = Nunavut) Inuvialuit
Settlement region
−0.096 −0.052, −0.008 0.008
Nunatsiavut 0.104 0.006, 0.035 0.006
R2 = 0.45, R2 adjusted = 0.44, n = 469.
Figure 1. Odds ratios for having a T-score for FaBMD consistent
with osteoporosis. Data are odds ratios and 95% CI for IFG cases
(n = 57), T2D cases (n = 72), compared to normoglycemic Inuit
women (n = 340); age (y) and BMI (kg/m2) were included as
continuous variables in the model.
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and T2D on bone quality and fracture risk in Inuit
women to establish if risk is as elevated as it is in
other Aboriginal groups [34].
This study is among very few studies that characterise
BMDof Inuitwomen. In a studybyAndersen et al. [35], BMD
was assessed in the distal forearm (and calcaneus) and was
found to be higher than the FaBMD values in the present
study. However, their participants were younger (30–49 y)
and the authors didnot address glucosemetabolismand its
impact on BMD. To our knowledge, there are no other
studies on the association between IFG or T2D and BMD
in Inuit. A meta-analysis that pooled many studies, regard-
less of ethnicity which was mainly Caucasian, found no
association between FaBMD and T2D, but a 0.04 g/cm2
increase in BMD at femoral neck and a 0.06 g/cm2 increase
in BMDat the total hip and lumbar spinewas observed [36].
Similar to our odds ratio analyses, a study among Chinese
women 40 y or older showed that the rate of BMD-based
assessments of osteoporosis is lower in women with T2D
relative to age-matched controls [37]. Conversely, a longer
duration (>10 y) of T2D associates with greater risk of
fracture in women over 40 y of age [34], and a recent
systematic review of Indigenous populations suggests
that Canada is among the few countries with an elevated
risk of hip fracture that associates with T2D [38]. This study
included some women with newly diagnosed T2D, and
combined with the challenges in obtaining an accurate
medical history, this precluded assessment of risk of frac-
tures according to duration of T2D. Hence,more studies are
needed to further explore the association between T2D,
BMD and fracture rates in Inuit over time.
Of the other lifestyle variables explored in this study,
smoking was fairly common with 37% of the women
reporting being a current smoker. After accounting for
well-known covariates (age, BMI, height), smoking was
weakly yet inversely related to FaBMD. The rate of smok-
ing was aligned with 43% reported for women >55 y in
the Aboriginal Peoples Survey [39]; the odds ratio of
smoking among Inuit women was lower among those
with a postsecondary education and residence within
food-secure homes. Smoking is reported to increase the
risk of fracture regardless of frequency [40,41], whereas
the impact on radial BMD is minimal [42,43]. Future stu-
dies that prospectively capture incident fracture will be
required to clarify the adverse effects of smoking in this
population.
Strengths and limitations
The IPY-HIS was designed to provide baseline data for
longitudinal assessments of Inuit health [19]. It is how-
ever not without limitations including the small sample
size for those with IFG and T2D, inclusion of women 40
y of age and older without a healthy young reference
group specific to Inuit, and without data regarding
menopausal status. Having women above and below
50 y of age challenged our assessment of osteoporosis
based on WHO guidelines where T-scores are usually
applied only to those 50 y of age and over. In addition,
the only assessment for bone that was feasible was
FaBMD owing to the remote regions studied; assess-
ment at other sites is needed to build upon the results
of this study. Moreover, the food frequency question-
naire assessed the frequency of traditional food over a
year based on recall and did not assess market food
dietary patterns. Further research regarding actual age
at menopause, and other lifestyle variables not cap-
tured (alcohol, exercise) in this report, are also needed
since these major factors are likely to confound the
association between dysglycemia and markers of osteo-
porosis. The assessment of other biomarkers of bone
metabolism and long-term biomarkers of glucose con-
trol (HbA1c) would have improved our understanding
of the relationship between bone health and IFG and
T2D. Finally, data on the duration of previously diag-
nosed T2D and complete fracture history were not
always available.
Conclusions
In summary, in this study we found that IFG and T2D
did not have adverse associations with FaBMD, and
FaBMD T-scores in Inuit women. Osteoporosis, as
defined by a T-score of −2.5 or less, was low (8.5%)
overall. This is potentially important since recently,
BMD of the radius has emerged as protective against
all-cause mortality in women with T2D [44]. Frequency
of marine mammal intakes was positively associated
with FaBMD. Fish intake is protective from T2D in
other populations [30], and based on our results, mar-
ine mammals may confer protection to bone as well
[15]. The intake of traditional foods should be encour-
aged among Inuit women.
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